80029742: Lipid Disorders Training Center: State of the Art and Science of Lipidology and Coronary Artery Disease

Accreditation Statement The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Statement The Johns Hopkins University School of Medicine designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. OTHER CREDIT American Academy of Family Physicians This Live activity, Lipid Disorders Training Center: State of the Art and Science of Lipidology and Coronary Artery Disease with a beginning date of October 20, 2012, has been reviewed and is acceptable for up to 8.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description

The level of sophistication and knowledge of lipidology is increasing in all medical specialties. While many physicians and medical specialists are gaining the knowledge to prevent and/or manage common lipid disorders, there is a growing need for those with greater interest and knowledge in the field to share ground-breaking research and explore controversial areas that may stimulate more sophisticated clinical care. This activity expands upon the requisite knowledge of lipid disorders and analyzes more complex diagnosis and treatment methods to manage complicated cases.

Objectives

After attending this activity, the participant will demonstrate the ability to:

• Evaluate the effects of PCSK9 on LDL and Lp (a) levels
• Discuss the importance of ApoA-I mimetic peptides in the treatment of CAD
• Recognize the new breakthroughs in human biology and medicine provided by microRNAs
• Differentiate between the associations of LDL and HDL molecular variants with myocardial infarction
• Evaluate the effects of CETP inhibitors on CAD
• Evaluate the utility of niacin in the treatment of dyslipidemia, low HDL and CAD

Talks

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.